PTC Therapeutics appoints biotech banking veteran Jessica Chutter to board

PTC THERAPEUTICS, INC.

Jessica Chutter appointed to board effective March 24, 2026, as Class I director.
Chutter spent 40+ years at Morgan Stanley, most recently as Managing Director and Chair of Biotech Investment Banking.
She was involved in ~$80B in capital raising and ~$85B in strategic transactions at Morgan Stanley.
Initial director equity grant: 3,475 stock options (36-month monthly vest) and 4,000 RSUs (3-year annual vest).
Also receives pro-rated annual grant: 2,896 stock options and 3,333 RSUs; eligible for future grants per board policy.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jessica Chutter

Director

PTC THERAPEUTICS, INC.

Effective: 2026-03-24
Filed: Mar 25, 2026 23:59 UTC

On March 24, 2026, PTC Therapeutics, Inc., (the “Company”) appointed Jessica Chutter to its board of directors (the “Board”), effective immediately, filling a vacancy on the Board.

Source: SEC EDGAR

accession 0001104659-26-034207

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.